Woodline Partners LP Vor Biopharma Inc. Transaction History

Woodline Partners LP

  • $11 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$12.24 - $20.38 $432,941 - $720,860
-35,371 Reduced 3.09%
1,111,123 $17.4 Million
Q2 2021

Aug 16, 2021
SELL
$18.65 - $38.78 $126,316 - $262,656
-6,773 Reduced 0.59%
1,146,494 $21.4 Million
Q1 2021

May 17, 2021
BUY
$30.96 - $54.08 $35.7 Million - $62.4 Million
1,153,267 New
1,153,267 $49.7 Million

Others Institutions Holding VOR

# of Institutions
58
Shares Held
41.2M
Call Options Held
9.3K
Put Options Held
100
View Full List

About Vor Biopharma Inc.

VOR Quotes by TradingView
  • Ticker VOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,056,300
  • Market Cap $32.7M
  • Description
  • Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...
More about VOR
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email